Stocky
LBRX
LB Pharmaceuticals Inc Common Stock
NASDAQ · Healthcare · US
45.03
▲ +0.07%

What's happening at LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock's latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 5 Aug 2026
Big update 29 Jul 2026

Company raises capital through private placement of shares

Private placements bring money into the company to fund operations and drug development.

SEC 424B3 · filed 2026-07-29 View filing ↗
Money 29 Jul 2026

Company raises capital through private placement of shares

Private placements bring money into the company to fund operations and drug development.

SEC 8-K · filed 2026-07-29 View filing ↗
Money 22 Jul 2026

Stock price at $32.31 per share on July 21, 2026

Stock price shows what investors are willing to pay for company ownership.

SEC 424B3 · filed 2026-07-22 View filing ↗
Deal 22 Jul 2026

NOVA-2 Phase 3 trial results timeline accelerated

Faster drug trial results could mean quicker approval path and potential future revenue.

SEC 8-K · filed 2026-07-22 View filing ↗
Money 10 Jun 2026

Stock price at $29.27 per share on June 9, 2026

Stock price shows what investors are willing to pay for company ownership.

SEC 424B3 · filed 2026-06-10 View filing ↗
People 10 Jun 2026

Chief Medical Officer Anna Eramo transitions to advisory role

Leadership changes affect who makes decisions about drug development and company strategy.

SEC 8-K · filed 2026-06-10 View filing ↗
Money 9 Jun 2026

Stock price at $29.40 per share on June 8, 2026

Stock price shows what investors are willing to pay for company ownership.

SEC 424B3 · filed 2026-06-09 View filing ↗

Common questions

How does Stocky track LB Pharmaceuticals Inc Common Stock's company events?

Stocky reads LB Pharmaceuticals Inc Common Stock's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was LB Pharmaceuticals Inc Common Stock's most recent SEC filing?

LB Pharmaceuticals Inc Common Stock's most recent tracked filing was a 424B3 on 29 Jul 2026: Company raises capital through private placement of shares.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See LB Pharmaceuticals Inc Common Stock's full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.